Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
April 29 2022 - 7:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of April 2022
Commission
File Number: 001-39803
Meiwu
Technology Company Limited
(Translation
of registrant’s name into English)
1602,
Building C, Shenye Century Industrial Center
No.
743 Zhoushi Road, Bao’an District Shenzhen, People’s Republic of China
Telephone:
+86-755-85250400
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Note:
Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report
to security holders.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Note:
Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that
the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on
which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to
be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the
subject of a Form 6-K submission or other Commission filing on EDGAR.
On
April 28, 2022, Meiwu Technology Company Limited (the “Company”) entered into certain Securities Purchase Agreement
(the “SPA”) with five “accredited investors” as defined in Rule 501(a) of Regulation D as promulgated
under the Securities Act of 1933, as amended (the “Securities Act”) (the “Purchasers”), pursuant
to which the Company agreed to sell to each of such Purchasers an unsecured convertible note with an original principal amount of $1,100,000
(the “Note”) and accompanying warrants (the “Warrants”) to purchase 1,600,000 ordinary shares
of the Company (the “Offering”). The Company shall receive $1,000,000.00 in gross proceeds for each Note and its accompanying
Warrants. The Warrants will be exercisable immediately upon the date of issuance and have an initial exercise price of $0.60. The Warrants
will expire twenty- four months from the date of issuance.
Each
of the Notes bears interest at a rate of 10% per annum compounding daily. All outstanding principal and accrued interest on the Notes
will become due and payable eighteen (18) months after the issuance date. Each of the Note includes an original issue discount of $100,000.00
along with $4,000.00 for Purchasers’ fees, costs and other transaction expenses incurred in connection with the purchase and sale
of the Notes. The Company may prepay all or a portion of the Note at any time by paying 120% of the outstanding balance elected for pre-payment.
Each of the Purchasers can convert his or her Note at any time after the six-month anniversary of the issuance date at a conversion price
of the lower of (i) $0.50 or (ii) 80% of the lowest daily volume-weighted average price in the 20 trading days prior to the date on which
the conversion price is measured (the “Market Price”). In addition, the Purchasers agreed that in any given calendar
week (being from Sunday to Saturday of that week), the number of Ordinary Shares sold by it in the open market will not be more than
fifteen percent (15%) of the weekly trading volume for the Ordinary Shares during such week.
The
Notes, the Ordinary Shares underlying the Notes, the Warrants, and Ordinary Shares issuable upon exercise of the Warrants, are exempt
from the registration requirements of the Securities Act, pursuant to Section 4(a)(2) of the Securities Act and/or Regulation D.
The
proceeds of this Offering will be used for working capital and general corporate purposes .
The
SPA also contains customary representation and warranties of the Company and the Purchasers, indemnification obligations of the Company,
termination provisions, and other obligations and rights of the parties.
The
Form of the SPA, the form of the Note, the form of the Warrants are filed as Exhibits 10.1, 10.2 and 4.1 to this Current Report on Form
6-K, respectively; and such documents are incorporated herein by reference. The foregoing is only a brief description of the material
terms of the SPA, the Note, and the Warrants, and does not purport to be a complete description of the rights and obligations of the
parties thereunder and are qualified in their entirety by reference to such exhibits.
Exhibits
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
Meiwu Technology Co. Ltd. |
|
|
|
|
By: |
/s/
Xinliang Zhang |
|
|
Xinliang Zhang |
|
|
Chief Executive Officer |
|
|
|
Date: April 29, 2022 |
|
|
Meiwu Technology (NASDAQ:WNW)
Historical Stock Chart
From Dec 2024 to Jan 2025
Meiwu Technology (NASDAQ:WNW)
Historical Stock Chart
From Jan 2024 to Jan 2025